Target effector role of vascular endothelium in the inflammatory response: insights from the clinical trial of anti-TNF alpha antibody in rheumatoid arthritis.

Por Paleolog, E
Publicado em 1997

Angiogenesis and arthritis: a potential therapeutic target?

Por Grosjean, J, Sivakumar, B, Paleolog, E
Publicado em 2004

Selective enhancement of endothelial cell VCAM-1 expression by interleukin-10 in the presence of activated leucocytes.

Por Fiehn, C, Paleolog, E M, Feldmann, M
Publicado em 1997

Dexamethasone up-regulates granulocyte-macrophage colony-stimulating factor receptor expression on human monocytes.

Por Hawrylowicz, C M, Guida, L, Paleolog, E
Publicado em 1994

The roles of protein kinase C and intracellular Ca2+ in the secretion of von Willebrand factor from human vascular endothelial cells.

Por Carew, M A, Paleolog, E M, Pearson, J D
Publicado em 1992

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis

Por Maini, R, Taylor, P, Paleolog, E, Charles, P, Ballara, S, Brennan, F, Feldmann, M
Publicado em 1999

Future prospects for anti-cytokine treatment

Por Feldmann, M., Miotla, J., Paleolog, E., Williams, R., Malfait, A., Taylor, P., Brennan, F., Maini, R.
Publicado em 2000

Diagnostic strategy for the assessment of rheumatoid vasculitis

Por Voskuyl, A, Hazes, J, Zwinderman, A, Paleolog, E, van der Meer, F J M, Daha, M, Breedveld, F
Publicado em 2003

The effect of tumour necrosis factor-α (TNF-α) muteins on human neutrophils in vitro

Por Tchorzewski, H., Zeman, K., Kantorski, J., Paleolog, E., Kahan, M., Feldmann, M., Kwinkowski, M., Guga, P., Szymanska, B., Parniewski, P., Wilk, A., Jarosz, J.
Publicado em 1993

Is NF-κB a useful therapeutic target in rheumatoid arthritis?

Por Feldmann, M, Andreakos, E, Smith, C, Bondeson, J, Yoshimura, S, Kiriakidis, S, Monaco, C, Gasparini, C, Sacre, S, Lundberg, A, Paleolog, E, Horwood, N, Brennan, F, Foxwell, B
Publicado em 2002